MarketPulse
S

$SIGA

1 article found
0 positive
1 negative
0 neutral
GlobeNewswire Inc.GlobeNewswire Inc.··Actg

Tecovirimat Shows No Clinical Benefit Over Placebo in Mpox Trial

Tecovirimat showed no clinical benefit over placebo in treating mpox, with 79% vs 81% achieving resolution by day 29 in a major trial.
SIGAclinical trialtecovirimat